GOOG
65
-4
ROK
55
8
JWN
40
-2
AMAT
36
5
URBN
38
-4
CF
59
3
BAC
50
-3
MDLZ
34
2
IP
70
2
XEL
67
2
CAH
47
3
PPL
54
2
EFX
32
2
MCO
73
3
TXT
48
2
A
36
2
DVA
72
2
STI
47
-12
EL
20
3
ZBH
60
-2
GOOG
65
-4
ROK
55
8
JWN
40
-2
AMAT
36
5
URBN
38
-4
CF
59
3
BAC
50
-3
MDLZ
34
2
IP
70
2
XEL
67
2
CAH
47
3
PPL
54
2
EFX
32
2
MCO
73
3
TXT
48
2
A
36
2
DVA
72
2
STI
47
-12
EL
20
3
ZBH
60
-2
Financhill
Back

InMed Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32

INM
InMed Pharmaceuticals

Last Price:
4.56
Seasonality Move:
17.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

InMed Pharmaceuticals Price Quote

$4.56
+0.33 (+7.8%)
(Updated: November 21, 2024 at 5:55 PM ET)

InMed Pharmaceuticals Key Stats

Sell
32
InMed Pharmaceuticals (INM) is a Sell
Day range:
$4.09 - $4.33
52-week range:
$2.41 - $15.70
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.30
P/B ratio:
0.36%
Volume:
20.5K
Avg. volume:
57.1K
1-year change:
-47.76%
Market cap:
$3M
Revenue:
$4.6M
EPS:
$-65.4

How Much Does InMed Pharmaceuticals Make?

Is InMed Pharmaceuticals Growing As A Company?

  • What Is InMed Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.4%
  • What Is InMed Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

InMed Pharmaceuticals Stock Price Performance

What Is InMed Pharmaceuticals 52-Week High & Low?

InMed Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy InMed Pharmaceuticals?

Is InMed Pharmaceuticals Cash Flow Positive?

  • What Is INM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$6.6M
  • What Is InMed Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.5M
  • What Is InMed Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$9.3K

InMed Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    INM return on invested capital is -66.76%
  • What Is InMed Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -55.13%
  • What Is INM Return On Equity?
    ROE is a measure of profitability and is -66.76%

InMed Pharmaceuticals Earnings Date & Stock Price

InMed Pharmaceuticals Competitors

InMed Pharmaceuticals Dividend Yield

InMed Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 40.23% -21.35%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 409.42
Upside from Last Price: 9578.96%

Major Shareholders

  • How many INM shares are owned by institutional investors?
    2.1M INM shares are owned by institutional investors
  • How many INM shares are owned by insiders?
    400.1K INM shares are owned by insiders